Stemtech Statistics
Total Valuation
Stemtech has a market cap or net worth of 3.19 million. The enterprise value is 6.64 million.
| Market Cap | 3.19M |
| Enterprise Value | 6.64M |
Important Dates
The last earnings date was Tuesday, April 1, 2025.
| Earnings Date | Apr 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Stemtech has 136.47 million shares outstanding. The number of shares has increased by 61.66% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 136.47M |
| Shares Change (YoY) | +61.66% |
| Shares Change (QoQ) | +3.27% |
| Owned by Insiders (%) | 29.41% |
| Owned by Institutions (%) | 8.90% |
| Float | 91.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.63 |
| PB Ratio | -0.54 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.27 |
| EV / Sales | 1.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.08
| Current Ratio | 0.08 |
| Quick Ratio | 0.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.39 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -61.74% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 64.64% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.31 |
| Inventory Turnover | 9.40 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.12% in the last 52 weeks. The beta is 2.23, so Stemtech's price volatility has been higher than the market average.
| Beta (5Y) | 2.23 |
| 52-Week Price Change | -65.12% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.04 |
| Relative Strength Index (RSI) | 36.67 |
| Average Volume (20 Days) | 459,556 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.00 |
Income Statement
In the last 12 months, Stemtech had revenue of 5.10 million and -5.24 million in losses. Loss per share was -0.05.
| Revenue | 5.10M |
| Gross Profit | 3.82M |
| Operating Income | -3.85M |
| Pretax Income | -5.24M |
| Net Income | -5.24M |
| EBITDA | -3.35M |
| EBIT | -3.85M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 260,344 in cash and 4.45 million in debt, giving a net cash position of -4.19 million or -0.03 per share.
| Cash & Cash Equivalents | 260,344 |
| Total Debt | 4.45M |
| Net Cash | -4.19M |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | -5.95M |
| Book Value Per Share | -0.04 |
| Working Capital | -8.81M |
Cash Flow
| Operating Cash Flow | -713,495 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 74.96%, with operating and profit margins of -75.40% and -102.67%.
| Gross Margin | 74.96% |
| Operating Margin | -75.40% |
| Pretax Margin | -102.71% |
| Profit Margin | -102.67% |
| EBITDA Margin | -65.59% |
| EBIT Margin | -75.40% |
| FCF Margin | n/a |
Dividends & Yields
Stemtech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -61.66% |
| Shareholder Yield | -61.66% |
| Earnings Yield | -164.02% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Stemtech has an Altman Z-Score of -16.39. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -16.39 |
| Piotroski F-Score | n/a |